• Pin It
  • Pin It

British ministers press for post-Brexit pharma deal

Jul 04, 2017, 7:11 AM EDT
Britain's Business Secretary Greg Clark
(Source: Policy Exchange/flickr)

In a letter to the Financial Times, two British ministers have urged the country to find a way to maintain “a deep, broad and dynamic” post-Brexit cooperation with the European Union in life sciences sector to ensure steady investment and secure the interests of public health and safety.

The letter by Business Secretary Greg Clark and Health Secretary Jeremy Hunt highlights concerns that need attention, for example, will the U.K. patients have to wait longer if the drug authorizing body, European Medicines Agency (EMA) currently based in London, moves out of the U.K. after Brexit, notes the BBC.  

Life sciences sector, which provides about 220,000 jobs in the U.K. and generates £60bn a year, has been worried that the uncertainty in the government’s position over pharmaceutical industry during the course of Brexit could cost investors’ confidence, writes Financial Times.